Gynecology/Obstetrics News

New research has revealed that additional cervical cancer screenings may elevate the risk for preterm delivery among young women.

Menopause education and resources vary across OB/GYN residency programs in the U.S., with most lacking a dedicated menopause curriculum, according to survey results published in Menopause.

Severe maternal morbidity rates increased across nearly every racial and ethnic group between 2008 and 2018, according to a study conducted by researchers at Johns Hopkins Bloomberg School of Public Health.

Undergoing more cervical cancer screenings was associated with an increased risk for preterm birth among women aged 18 to 24 years, especially among those with hypertension or diabetes, researchers reported.

Menopausal women experience multiple vulvovaginal symptoms with variations in quantity, severity and frequency, which cause significant interference in daily life, according to a post hoc analysis published in Menopause.

Last month, Pfizer announced that it was facing a “limited supply and impending stock out” for two of its injectable penicillin products, in part because of a surge in syphilis infections.

Among premenopausal women in Korea, family history of breast cancer was positively associated with increased breast density and persistently dense breasts over time, according to findings published in JAMA Network Open.

A phase 1/2 clinical trial found that a vaginal tamoxifen capsule was safe in postmenopausal women with vulvovaginal atrophy, researchers reported.

A Michigan statewide analysis found significant variations in surgical approaches for hysterectomies performed to treat pelvic organ prolapse, according to study data.

So far in 2023, there has been an overwhelming shortage of chemotherapy drugs, of which several specifically impact gynecologic oncology providers and patients.